Bayer Lunch Symposium: Personalized Treatment of Hepatocellular Carcinoma: Seeking Solutions Through Multidisciplinary Collaboration

Bayer Lunch Symposium

  • Exploring the infrastructure for personalised management of hepatocellular carcinoma (HCC)
    Josep M. Llovet, MD (Spain/USA)

  • Locoregional therapy of HCC: opportunities and limitations
    Riccardo Lencioni, MD (Italy)

  • Systemic targeted therapy in HCC: Are we making progress?
    Andrew Zhu, PhD (USA)